| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |